CD4 and neoplasm: Consistently in vitro, T cells in the tumor microenvironment were higher in CG-745 (CD4 (8.62%) and CD8 (7.19%)) than in vehicle group (CD4 (1.73%) and CD8 (1.51%)) (Figure 6A).